CMS (Centers for Medicare and Medicaid Services) makes Guidant, Medtronic wait on ICDs (implantable cardioverter defibrillators) coverage decision
This article was originally published in Clinica
Executive Summary
Guidant and Medtronic will have to wait a few more weeks before the Centers for Medicare and Medicaid Services decides whether Medicare should cover the use of implanted cardioverter defibrillators (ICDs) to prevent sudden cardiac arrest in patients whose heart can no longer pump adequately as a result of a heart attack.